Propel Bio Management »

Satellos Bioscience shares owned by Propel Bio Management

Quarter-by-quarter ownership of Satellos Bioscience shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Satellos Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Satellos Bioscience held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Satellos Bioscience by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $57k 10k 5.63

More positions owned by Propel Bio Management

Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Achieve Life Sciences (ACHV)
Phathom Pharmaceuticals (PHAT)
Delcath Sys Com New (DCTH)
Corcept Therapeutics Incorporated (CORT)
Abeona Therapeutics Com New (ABEO)
Vor Biopharma Com New (VOR)
Kyverna Therapeutics (KYTX)
Milestone Pharmaceuticals (MIST)
Celldex Therapeutics Com New (CLDX)
Compass Pathways Sponsored Ads (CMPS)
Miragen Therapeutics (VRDN)
Inventiva Sa Ads (IVA)
Sab Biotherapeutics Com New (SABS)
Health Sciences Acq Corp 2 (OBIO)

View all positions for Propel Bio Management

Top funds holding Satellos Bioscience

Franklin Resources
Vivo Capital
Point72 Asset Management
Woodline Partners
Sphera Funds Management
Suvretta Capital Management
Soleus Capital Management
Avidity Partners Management
Millennium Management
683 Capital Management
Empery Asset Management
ADAR1 Capital Management
Citadel Advisors
Hrt Financial
Morgan Stanley

View all funds holding Satellos Bioscience